Does Metformin Cause Dizziness?
Yes, metformin can cause dizziness, but this is not a common direct side effect of the medication itself—rather, dizziness typically occurs as a symptom of serious complications like lactic acidosis or hypoglycemia when metformin is combined with other glucose-lowering agents.
Primary Mechanism: Lactic Acidosis Warning
The FDA drug label explicitly lists dizziness or lightheadedness as a warning symptom of lactic acidosis, which is a rare but life-threatening complication of metformin 1. Patients experiencing dizziness should be evaluated immediately for:
- Unusual weakness or fatigue
- Muscle pain
- Trouble breathing
- Stomach problems with nausea/vomiting
- Feeling cold in extremities
- Slow or irregular heartbeat
If dizziness occurs with any of these symptoms, stop metformin immediately and seek emergency care 1.
Secondary Mechanism: Hypoglycemia
Dizziness can occur when metformin is combined with sulfonylureas or insulin, as these combinations increase hypoglycemia risk 1. A 2022 comparative toxicology study found that sulfonylurea exposure was significantly more likely to cause dizziness or vertigo compared to metformin (biguanide) exposure 2. However, isolated case reports document symptomatic hypoglycemia with therapeutic metformin doses, presenting with dizziness, diaphoresis, weakness, and confusion 3.
Clinical Context: Not a Common Direct Side Effect
The most common adverse reactions to metformin (occurring in >5% of patients) are gastrointestinal: diarrhea (53%), nausea/vomiting (26%), flatulence (12%), and abdominal discomfort 1. Dizziness is not listed among the primary adverse reactions in clinical trials 1.
In postmarketing surveillance and clinical trials, "lightheaded" was reported in only 1-5% of patients and was more common than placebo 1. This suggests dizziness is an uncommon direct effect.
Risk Factors Requiring Vigilance
Patients at higher risk for metformin-related complications (and thus dizziness as a warning sign) include those with:
- Kidney dysfunction (eGFR <30 mL/min/1.73 m²)—metformin accumulation increases lactic acidosis risk 4, 5
- Liver problems or heart failure requiring treatment
- Dehydration from illness, vomiting, or inadequate fluid intake
- Concurrent use of insulin or sulfonylureas 1
A 2022 case report documented a 53-year-old woman with CKD (baseline eGFR 45) who presented with dizziness and lightheadedness, later diagnosed with metformin-associated lactic acidosis (MALA) requiring emergent dialysis 6.
Practical Management Algorithm
When a patient on metformin reports dizziness:
- Immediately assess for lactic acidosis symptoms (weakness, dyspnea, abdominal pain, altered mental status)—if present, discontinue metformin and transfer to emergency care
- Check blood glucose—if <70 mg/dL and patient is on sulfonylurea/insulin combination, treat hypoglycemia
- Review renal function—if eGFR <30, discontinue metformin; if 30-45, reduce dose and provide sick-day education 4
- Evaluate hydration status—dehydration increases lactic acidosis risk
- Consider alternative causes—dizziness is rarely an isolated metformin effect
Key Takeaway
Dizziness with metformin should trigger immediate evaluation for lactic acidosis or hypoglycemia rather than being dismissed as a benign side effect. The 2025 ADA guidelines emphasize that metformin is safe when used appropriately with proper renal monitoring 4, but dizziness represents a potential red flag requiring prompt clinical assessment.